The Japan hemostats market size was estimated at USD 214.84 million in 2025 to reach nearly USD 403.28 million by 2035, and is expanding at a CAGR of 6.50% from 2026 to 2035. A growing aging population and rising surgeries are driving the market.

Japan Hemostats Market Statical Scope

Hemostats, also known as hemostatic forceps or arterial forceps, are surgical instruments used to control bleeding during surgical procedures or to grasp and hold tissues or blood vessels. The hemostats market includes a variety of hemostatic agents and tools designed to manage bleeding in medical and surgical settings. Hemostats are commonly used in both minor and major surgeries, as well as in various medical environments such as emergency rooms and dental offices.

Several key factors are driving growth in the hemostats market in Japan. Firstly, the increasing number of surgical procedures in Japan has created a strong demand for hemostatic agents. As surgeries become more advanced and minimally invasive, the need for effective hemostatic tools to control bleeding during these procedures has surged. Additionally, the aging population significantly contributes to market expansion. With a growing elderly demographic, the incidence of chronic diseases and surgeries, such as cardiovascular and orthopedic procedures, has increased, further propelling the demand for hemostatic products.

Japan Hemostats Market Share, By Product, 2025, (%)

• Oxidized regenerated cellulose - based hemostats- Oxidized regenerated cellulose-based hemostats dominate the market, with a share of 47%, driven by their high efficiency, wide surgical applicability, and high use across multiple procedures.
• Thrombin - based hemostats- Thrombin-based hemostats hold a significant position, with a share of 22%, because of their quick action and efficiency in controlling bleeding.
• Combination hemostats - Combination hemostats account for a share of 18%, driven by their improved performance through multiple mechanisms of action.
• Others - Covers miscellaneous product types, with a 13% share, contributes moderately but does not dominate.

Japan Hemostats Market Share, By Formulation, 2025, (%)

• Matrix & gel hemostats - The matrix & gel hemostats segment leads the formulation segment, with a share of 38%, due to ease of application, strong adhesion, and effectiveness in complex surgical procedures.
• Sponge hemostats - Sponge hemostats hold a share of 27%, driven by their absorbent nature and widespread use in surgeries.
• Powder hemostats - Powder hemostats account for a share of 20%, mainly driven by their convenience in treating irregular wound surfaces.
• Others - Represents additional minor segments within another category, with a 15% share, contributes but remains below dominant segments.

Japan Hemostats Market Share, By End Use, 2025, (%)

• Hospitals & clinics - Hospitals & clinics dominate the market, with a share of 64%, driven by the rising number of surgeries, advanced medical infrastructure, presence of skilled healthcare professionals, and the growing number of complex procedures performed.
• Ambulatory surgical centers - Ambulatory surgical centers hold a significant portion, with a share of 18%, driven by the rising preference for outpatient surgeries, cost-effectiveness, and faster patient recovery times.
• Casualty care centers - Casualty care centers account for a share of 10%, driven by growing cases of emergency treatments, trauma care, and the demand for immediate bleeding control solutions.
• Others - Covers miscellaneous product types, with a 8% share, contributes moderately but does not dominate.

Japan Hemostats Market Share, By Application, 2025, (%)

• Orthopedic surgery - Orthopedic surgery dominates the market, with a share of 32%, driven by the rising incidence of bone-related injuries, fractures, and joint replacements.
• General surgery - General surgery holds a significant share, with a share of 26%, driven by the wide usage of hemostats across a broad range of routine and minimally invasive surgical procedures.
• Neurological surgery - Neurological surgery holds a notable share of 14%, driven by rising demand for delicate, high-precision procedures involving the brain and nervous system.
• Cardiovascular surgery - Cardiovascular surgery accounts for a significant portion, with a share of 18%, driven by the need for bleeding control during complex heart and vascular operations.
• Others - Represents additional minor segments within another category, with a 10% share, contributes but remains below dominant segments.

Top Companies in the Japan Hemostats Market

• Johnson & Johnson Services, Inc.
• CryoLife, Inc
• Integra LifeSciences Corporation
• Cohera Medical, Inc.
• Pfizer
• Cohesion Technologies
• B. Braun Melsungen AG
• Baxter
• Medtronic
• BD

Segments Covered in the Report

By Product

• Thrombin-based Hemostats
• Oxidized Regenerated Cellulose-based Hemostats
• Combination Hemostats
• Others

By Formulation

• Matrix & Gel Hemostats
• Sponge Hemostats
• Powder Hemostats
• Others

By End-use

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Casualty Care Centers
• Others

By Application

• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Others